| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10752608 | Biochemical and Biophysical Research Communications | 2015 | 6 Pages |
Abstract
In conclusion, hypoxia promoted the expansion of CSCs expressing CD133 and CD44 accompanied by an increase of stem cell factors. Its inhibition of hypoxia-induced CSC expansion makes TX-402 promising agent usable in combination for ovarian cancer therapy.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Noriko Nozawa-Suzuki, Hideko Nagasawa, Ken Ohnishi, Ken-ichirou Morishige,